• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Kremers Urban Pharms Generic Esomeprazole Magnesium Approved In US

    FDA

    Mylan cuts short J&J`s Concerta generics reprieve with new FDA nod

    FIERCE PHARMA

    Generic Drug Makers Challenge FDA Plan to Withdraw their ADHD Pills

    STAT

    Kremers Urban Pharms Generic Buprenorphine Hydrochloride Approved In US

    FDA

    Kremers Urban Pharm`s Generic Potassium Chloride approved in US for Hypokalemia

    FDA

    Kremers Urban Pharms Generic Temozolomide approved in US an anti-cancer chemotherapy drug

    FDA

    Lannett Announces Cost Savings And Restructuring Actions

    PR NEWSWIRE

    Tech Transfer Success At The MDC: US Approval For New Bleeding Disorder Drug

    PR NEWS WIRE

    Lannett completes acquisition of Kremers Urban Pharmaceuticals

    EUROPEAN PHARMACEUTICAL REVIEW

    Amgen M&A Speculation Heats Up With Four Potential Targets

    BIOSPACE

    Lannett Buys UCB`s U.S. Generics Division for $1.23 Billion

    BLOOMBERG BUSINESS

    Cipla only Indian firm in race for Kremers Urban

    THE ECONOMIC TIMES

    UCB Cancels Sale of Generic-Drug Unit to Buyout Firms

    BLOOMBERG

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.